TM2D2
gene geneOn this page
Also known as BLP1
Summary
TM2D2 (TM2 domain containing 2, HGNC:24127) is a protein-coding gene on chromosome 8p11.22, encoding TM2 domain-containing protein 2 (Q9BX73). It is a selective cancer dependency (DepMap: 13.5% of cell lines).
The protein encoded by this gene contains a structural module related to that of the seven transmembrane domain G protein-coupled receptor superfamily. This protein has sequence and structural similarities to the beta-amyloid binding protein (BBP), but, unlike BBP, it does not regulate a response to beta-amyloid peptide. This protein may have regulatory roles in cell death or proliferation signal cascades. This gene has multiple alternatively spliced transcript variants which encode two different isoforms.
Source: NCBI Gene 83877 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 36 total
- Cancer dependency (DepMap): dependent in 13.5% of screened cell lines
- MANE Select transcript:
NM_078473
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24127 |
| Approved symbol | TM2D2 |
| Name | TM2 domain containing 2 |
| Location | 8p11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BLP1 |
| Ensembl gene | ENSG00000169490 |
| Ensembl biotype | protein_coding |
| OMIM | 610081 |
| Entrez | 83877 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 8 protein_coding, 2 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000397070, ENST00000456397, ENST00000456845, ENST00000517872, ENST00000519186, ENST00000520152, ENST00000521060, ENST00000522142, ENST00000522434, ENST00000524331, ENST00000912343, ENST00000912344
RefSeq mRNA: 4 — MANE Select: NM_078473
NM_001024380, NM_001024381, NM_031940, NM_078473
CCDS: CCDS43733, CCDS6111
Canonical transcript exons
ENST00000456397 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001275041 | 38988808 | 38991545 |
| ENSE00002103558 | 38996213 | 38996509 |
| ENSE00003519832 | 38993545 | 38993660 |
| ENSE00003591975 | 38995318 | 38995405 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 94.66.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.3298 / max 177.2784, expressed in 1817 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 92773 | 28.3249 | 1817 |
| 92774 | 0.0049 | 2 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 94.66 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.37 | gold quality |
| ileal mucosa | UBERON:0000331 | 94.27 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.19 | gold quality |
| amniotic fluid | UBERON:0000173 | 94.15 | gold quality |
| decidua | UBERON:0002450 | 93.79 | gold quality |
| pancreatic ductal cell | CL:0002079 | 93.78 | gold quality |
| placenta | UBERON:0001987 | 93.61 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 93.34 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 93.33 | gold quality |
| sperm | CL:0000019 | 93.22 | gold quality |
| gall bladder | UBERON:0002110 | 92.95 | gold quality |
| visceral pleura | UBERON:0002401 | 92.76 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.76 | gold quality |
| parietal pleura | UBERON:0002400 | 92.69 | gold quality |
| endothelial cell | CL:0000115 | 92.68 | gold quality |
| monocyte | CL:0000576 | 92.40 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.30 | gold quality |
| leukocyte | CL:0000738 | 92.22 | gold quality |
| tibialis anterior | UBERON:0001385 | 91.84 | gold quality |
| oviduct epithelium | UBERON:0004804 | 91.63 | gold quality |
| calcaneal tendon | UBERON:0003701 | 91.62 | gold quality |
| adult organism | UBERON:0007023 | 91.29 | gold quality |
| lower lobe of lung | UBERON:0008949 | 91.24 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.15 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.11 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 91.09 | gold quality |
| skin of hip | UBERON:0001554 | 91.06 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.98 | gold quality |
| seminal vesicle | UBERON:0000998 | 90.96 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 43.26 |
| E-MTAB-2983 | no | 1211.29 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
96 targeting TM2D2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 13.5% of screened cell lines.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tm2d2 | ENSDARG00000035515 |
| mus_musculus | Tm2d2 | ENSMUSG00000031556 |
| rattus_norvegicus | Tm2d2 | ENSRNOG00000016559 |
| drosophila_melanogaster | amrt | FBGN0030522 |
| caenorhabditis_elegans | WBGENE00015353 |
Paralogs (2): TM2D1 (ENSG00000162604), TM2D3 (ENSG00000184277)
Protein
Protein identifiers
TM2 domain-containing protein 2 — Q9BX73 (reviewed: Q9BX73)
Alternative names: Beta-amyloid-binding protein-like protein 1
All UniProt accessions (4): E5RIQ5, E5RIT0, E5RJK9, Q9BX73
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Widely expressed.
Similarity. Belongs to the TM2 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BX73-1 | 1 | yes |
| Q9BX73-2 | 2 |
RefSeq proteins (4): NP_001019551, NP_001019552, NP_114146, NP_510882* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007829 | TM2 | Domain |
| IPR050932 | TM2D1-3-like | Family |
Pfam: PF05154
UniProt features (12 total): topological domain 3, glycosylation site 2, transmembrane region 2, signal peptide 1, chain 1, splice variant 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BX73-F1 | 81.63 | 0.55 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 92, 37
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 132 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, AHRARNT_01, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, CREBP1_Q2, TGACCTY_ERR1_Q2, BRUECKNER_TARGETS_OF_MIRLET7A3_DN, WEI_MYCN_TARGETS_WITH_E_BOX, TCF4_Q5, GARY_CD5_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, AACTTT_UNKNOWN, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN, TGGAAA_NFAT_Q4_01, TAATTA_CHX10_01
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TM2D2 | TM2D1 | Q9BX74 | 978 |
| TM2D2 | PLEKHA2 | Q9HB19 | 620 |
| TM2D2 | DDHD2 | O94830 | 582 |
| TM2D2 | PLPP5 | Q8NEB5 | 570 |
| TM2D2 | NHLRC2 | Q8NBF2 | 566 |
| TM2D2 | FAM110A | Q9BQ89 | 511 |
| TM2D2 | NSD3 | Q9BZ95 | 507 |
| TM2D2 | ERLIN2 | O94905 | 507 |
| TM2D2 | ZMAT4 | Q9H898 | 489 |
| TM2D2 | PLPBP | O94903 | 489 |
| TM2D2 | HTRA4 | P83105 | 483 |
| TM2D2 | LSM1 | O15116 | 459 |
| TM2D2 | NPRL2 | Q8WTW4 | 431 |
| TM2D2 | TM2D3 | Q9BRN9 | 429 |
| TM2D2 | BAG4 | O95429 | 428 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJB2 | TM2D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TM2D2 | TMEM97 | psi-mi:“MI:0914”(association) | 0.530 |
| PARP2 | TM2D2 | psi-mi:“MI:0557”(adp ribosylation reaction) | 0.440 |
| TM2D3 | SPINT1 | psi-mi:“MI:0914”(association) | 0.350 |
| MFSD10 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| GJB2 | TM2D2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): TM2D3 (Affinity Capture-MS), SIDT2 (Affinity Capture-MS), UQCC1 (Affinity Capture-MS), TMEM97 (Affinity Capture-MS), PCNXL3 (Affinity Capture-MS), UQCC2 (Affinity Capture-MS), SLC47A1 (Affinity Capture-MS), MBOAT7 (Affinity Capture-MS), PIGM (Affinity Capture-MS), ALG8 (Affinity Capture-MS), TMEM39A (Affinity Capture-MS), ERGIC2 (Affinity Capture-MS), SGPP1 (Affinity Capture-MS), TM2D2 (Affinity Capture-MS), TM2D2 (Positive Genetic)
ESM2 similar proteins: A0A1B0GRQ0, A0A1B0GVT2, A2RRL7, A3KN25, A4IFL1, G1TZA0, O18968, O54851, O70610, P08033, P0DKX4, P28230, P28234, P28235, P29414, P33725, P35212, P36382, P41987, P56513, Q01231, Q03190, Q08755, Q08EA8, Q0VCR2, Q2TA35, Q3MHM8, Q58CU5, Q5HZE8, Q5M8E3, Q5RCC0, Q60HF7, Q64448, Q6WGK6, Q7TNI2, Q866T7, Q8BSD4, Q8CFA6, Q8N6S5, Q8R0I4
Diamond homologs: A5PLF5, A5PLH4, P61228, Q07FZ2, Q2TA35, Q566R2, Q5M8E3, Q5RCC0, Q5XGR4, Q6DE06, Q6DHN3, Q8BJ83, Q8R0I4, Q95PJ8, Q95QZ5, Q99MB3, Q9BRN9, Q9BX73, Q9BX74, Q9U4H5, Q9VY86, Q9W2H1, Q9GPR3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
664 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:38993543:A:AC | donor_gain | 1.0000 |
| 8:38993544:C:CC | donor_gain | 1.0000 |
| 8:38995472:G:C | acceptor_gain | 1.0000 |
| 8:38995477:C:CT | acceptor_gain | 1.0000 |
| 8:38996211:A:AC | donor_gain | 1.0000 |
| 8:38996212:C:CC | donor_gain | 1.0000 |
| 8:38993537:ACACT:A | donor_loss | 0.9900 |
| 8:38993538:CACTT:C | donor_loss | 0.9900 |
| 8:38993539:ACTT:A | donor_loss | 0.9900 |
| 8:38993540:CTTAC:C | donor_loss | 0.9900 |
| 8:38993541:TT:T | donor_loss | 0.9900 |
| 8:38993542:TACT:T | donor_loss | 0.9900 |
| 8:38993543:ACTT:A | donor_loss | 0.9900 |
| 8:38993544:C:T | donor_loss | 0.9900 |
| 8:38993544:CT:C | donor_gain | 0.9900 |
| 8:38993544:CTTTA:C | donor_gain | 0.9900 |
| 8:38993656:CCGAA:C | acceptor_gain | 0.9900 |
| 8:38993657:CGAAC:C | acceptor_gain | 0.9900 |
| 8:38993658:GAAC:G | acceptor_loss | 0.9900 |
| 8:38993659:AAC:A | acceptor_loss | 0.9900 |
| 8:38993660:AC:A | acceptor_loss | 0.9900 |
| 8:38993661:C:CC | acceptor_gain | 0.9900 |
| 8:38993661:C:CG | acceptor_loss | 0.9900 |
| 8:38993662:T:A | acceptor_loss | 0.9900 |
| 8:38995313:CTCA:C | donor_loss | 0.9900 |
| 8:38995314:TCAC:T | donor_loss | 0.9900 |
| 8:38995315:CAC:C | donor_loss | 0.9900 |
| 8:38995316:A:AT | donor_loss | 0.9900 |
| 8:38995317:C:A | donor_loss | 0.9900 |
| 8:38995471:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
1371 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:38991347:C:A | W210C | 1.000 |
| 8:38991347:C:G | W210C | 1.000 |
| 8:38991349:A:G | W210R | 1.000 |
| 8:38991349:A:T | W210R | 1.000 |
| 8:38991387:A:T | L197Q | 1.000 |
| 8:38991396:A:G | L194P | 1.000 |
| 8:38991398:G:C | D193E | 1.000 |
| 8:38991398:G:T | D193E | 1.000 |
| 8:38991399:T:A | D193V | 1.000 |
| 8:38991399:T:C | D193G | 1.000 |
| 8:38991399:T:G | D193A | 1.000 |
| 8:38991400:C:G | D193H | 1.000 |
| 8:38991400:C:T | D193N | 1.000 |
| 8:38991409:A:G | W190R | 1.000 |
| 8:38991409:A:T | W190R | 1.000 |
| 8:38991412:A:G | W189R | 1.000 |
| 8:38991412:A:T | W189R | 1.000 |
| 8:38991417:C:T | G187E | 1.000 |
| 8:38991423:C:T | G185E | 1.000 |
| 8:38991424:C:G | G185R | 1.000 |
| 8:38991424:C:T | G185R | 1.000 |
| 8:38991426:C:A | G184V | 1.000 |
| 8:38991426:C:T | G184E | 1.000 |
| 8:38991427:C:G | G184R | 1.000 |
| 8:38991427:C:T | G184R | 1.000 |
| 8:38991438:A:G | L180P | 1.000 |
| 8:38991440:C:A | K179N | 1.000 |
| 8:38991440:C:G | K179N | 1.000 |
| 8:38991444:C:T | G178E | 1.000 |
| 8:38991473:G:C | F168L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000030858 (8:38993967 GCTTTACTTAT>G), RS1000331919 (8:38996639 C>T), RS1000716955 (8:38996653 T>C), RS1000754451 (8:38992499 AT>A), RS1000984841 (8:38992010 G>C), RS1000987417 (8:38990512 T>C,G), RS1001206948 (8:38996141 T>C), RS1001244347 (8:38993271 T>C), RS1001375936 (8:38998942 T>A,C), RS1001451867 (8:38997419 TC>T,TCC), RS1001654635 (8:38993581 G>A), RS1002331117 (8:38996809 G>A,T), RS1002388535 (8:38997597 G>A,T), RS1002654268 (8:38991776 G>A), RS1002700944 (8:38989285 T>C)
Disease associations
OMIM: gene MIM:610081 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | increases expression | 2 |
| Valproic Acid | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| deguelin | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Bortezomib | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Antimycin A | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | affects expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.